MENU

CLLS Cellectis SA Forecast, Technical & Fundamental Analysis

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications... Show more

Industry: #Biotechnology
Interact to see
Advertisement
View a ticker or compare two or three
Interact to see
Advertisement
A.I. Advisor
published Earnings

CLLS is expected to report earnings to fall 9.09% to -20 cents per share on March 04

Cellectis SA CLLS Stock Earnings Reports
Q4'26
Est.
$-0.20
Q2'26
Beat
by $0.04
Q1'26
Beat
by $0.08
Q4'25
Beat
by $0.03
Q3'25
Beat
by $0.24
The last earnings report on August 06 showed earnings per share of -21 cents, beating the estimate of -25 cents. With 18.68K shares outstanding, the current market capitalization sits at 107.77M.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HOOW16.980.63
+3.85%
Roundhill HOOD WeeklyPay ETF (HOOW)
XCEM43.861.06
+2.48%
Columbia EM Core ex-China ETF (XCEM)
CHNU22.470.34
+1.53%
Volatility Shares 2x Chainlink ETF (CHNU)
EDD5.490.03
+0.55%
Morgan Stanley Emerging Markets Domestic Debt Fund
RMNY23.60N/A
N/A
Rockefeller New York Municipal Bond ETF (RMNY)

CLLS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CLLS has been loosely correlated with SLN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CLLS jumps, then SLN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLLS
1D Price
Change %
CLLS100%
+3.88%
SLN - CLLS
43%
Loosely correlated
+0.05%
MDGL - CLLS
40%
Loosely correlated
-0.12%
PMVP - CLLS
38%
Loosely correlated
-1.18%
AXON - CLLS
36%
Loosely correlated
-18.18%
TGTX - CLLS
36%
Loosely correlated
+3.18%
More
A.I. Advisor
published General Information

General Information

a genome engineering company of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers

Industry Biotechnology

Industry
Biotechnology
Address
8, rue de la Croix Jarry
Phone
+33 181691600
Employees
186
Web
https://www.cellectis.com
Cellectis SA (CLLS) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com